Using the Chinese Indigenization FS Scale in the Diagnosis of Fibromyalgia: Specificity and Sensitivity in Clinical Practice

NCT06533410 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2024-10-21

No results posted yet for this study

Summary

This study aimed to evaluate the specificity and sensitivity of the diagnostic criteria for fibromyalgia after conducting local validation in China.

Conditions

  • Fibromyalgia

Interventions

DIAGNOSTIC_TEST

The FM Diagnosis and Assessment Scale will be filled out, and there will be no other interventions beyond that

The FM Diagnosis and Assessment Scale will be filled out, and there will be no other interventions beyond that

Sponsors & Collaborators

  • Hebei Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER_GOV
  • BAODING NO.1 HOSPITAL OF TCM

    collaborator UNKNOWN
  • Inner Mongolia Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • Shenzhen Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • Suzhou Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-21
Primary Completion
2025-03-31
Completion
2025-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06533410 on ClinicalTrials.gov